Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3700 3762 3792 3796
This examiner grants 84% of resolved cases
Catherine M Voorhees works in Tech Center 3700 and Art Unit 3700. The examiner has 877 resolved cases. The allowance rate is 83.5 percent. This high rate indicates that the majority of applications are eventually granted. Practitioners should find this examiner to be relatively accessible in terms of achieving a patent grant.
The interview lift is 14.0 percent. This positive lift suggests that interviews can further improve the 83.5 percent allowance rate. Practitioners should use this information to decide when to engage in direct discussion to resolve rejections. The data indicates that verbal communication is a helpful tool for advancing an application toward a grant.
The median days to allowance is 942. This timeline represents the typical duration for successful applications. With 877 resolved cases, the examiner has a well-established history of resolutions. This volume of data provides a reliable basis for understanding the examiner's performance and typical timelines for patent issuance.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18894345 | PERCUTANEOUS BLOOD PUMP WITH OUTFLOW BLOCKING SLEEVE | Final Rejection | Boston Scientific Scimed, Inc. |
| 18791881 | ICE-OPTIMIZED LEFT ATRIUM AND LEFT ATRIAL APPENDAGE PACING | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18797122 | METHODS AND SYSTEMS FOR CONTROL AND MODIFICATION OF STIMULATION | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 18835814 | PADDLE LEAD | Final Rejection | BIOTRONIK SE & Co. KG |
| 18441857 | SENSOR DATA DISPLAY BOUNDARY DETERMINATION | Final Rejection | Cardiac Pacemakers, Inc. |
| 18435131 | ACTIVELY INFLUENCING A STATE OF A USER OF A COMPUTING DEVICE | Final Rejection | Nvidia Corporation |
| 18781949 | DETERMINING POST-SHOCK TREATMENT BASED ON HEART VIABILITY | Non-Final OA | Physio-Control, Inc. |
| 19207303 | TREATMENT PARADIGMS FOR NERVE STIMULATION | Final Rejection | ElectroCore, Inc. |
| 18029500 | ADVANCED SURGICALLY IMPLANTABLE TECHNOLOGIES | Final Rejection | COCHLEAR LIMITED |
| 18757028 | TRANSDUCERS FOR DELIVERY OF TUMOR TREATING FIELDS AND CAPABLE OF REDUCING CREASING | Final Rejection | Novocure GmbH |
| 18604694 | COMBINED RF FRACTIONAL AND NON-FRACTIONAL TREATMENT | Final Rejection | Inmode Ltd. |
| 18727687 | APPLICATOR AND APPLICATOR ASSEMBLY FOR MEDICAL DEVICE | Final Rejection | l-SENS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy